Clinical Trial

Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 21, 2024 (before its estimated April 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy and safety of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing urethral stricture recurrence after direct visual internal urethrotomy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-17.
Status change: Not Yet Recruiting → Recruiting 2024-11-20
Trial Details
NCT Number NCT06697106
Lead Sponsor New Valley University
Conditions COX-2 Inhibitor, Meloxicam, Stricture Recurrence, Direct Vision Internal Urethrotomy
Enrollment 82 participants
Start Date 2024-11-20
Primary Completion 2025-04-01 (estimated)
Study Completion 2025-04-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-21